GENERAL Management &
XiangQIAN (XQ) LIN
Wharton-educated seasoned innovator, entrepreneur, and investor who is the Chairman and Founding Managing Director of EVX Ventures, Group President & CEO of Esco group, as well as co-founder of multiple biotech startups, including PairX Bio and Carmine Therapeutics.
Chief Scientific Officer
Yann Chong Tan,Phd
Stanford-educated serial entrepreneur and a successful inventor with extensive experience in the biotech space, who co-founded and held senior leadership roles in Atreca, a Nasdaq-listed biotech, and Nuevocor.
A pioneer in nucleic acid therapeutics at Alnylam Pharmaceuticals and held senior leadership positions at prominent pharmaceutical companies including Aligos Therapeutics, Janssen Pharmaceuticals and Spring Bank Pharmaceuticals. Co-author of 27 scientific publications and co-inventor on 22 issued or pending patents.
Sergei m. gryaznov,PHD
A leader in nucleic acid therapeutics who held key leadership roles in Janssen Pharma (part of Johnson and Johnson family of companies), Geron Corporation and MAIA Bio-technology. Co-author of more than 120 scientific publications and co-inventor on more than 50 issued or pending patents.
MD/PhD scientist with more than 10 years of experience in iPSC and translational regenerative medicine. Co-author of 15 scientific publications and co-developer of multiple technologies and therapies related to eye disease and oncology.
Senior Director, Biology
Si hui tan,PHD
Stanford-educated cancer biologist with publications in Nature and Science and more than 10 years’ research experience in cancer, stem cell and regeneration. In recognition of her outstanding research, she was awarded several grants and the President’s Young Scientist Award.
US-trained organic chemist with extensive research experience in nucleic acid chemistry and biomedical application of nucleic acids. Co-author of multiple scientific publications and co-inventor on several patents.
Associate Director, Operations and Project Management
Harvard-educated life science and medtech/biotech professional with more than 15 years’ experience in biological research, technology scouting as well as product and clinical management. Co-author of multiple scientific publications.
Professor Harvey Lodish
Founding Member of the Whitehead Institute for Biomedical Research, as well as Professor of Biology and a Professor of Biological Engineering at the Massachusetts Institute of Technology (MIT). Elected into the US National Academy of Sciences.
Seasoned scientist with over 2 decades of target discovery experience for liver diseases. Principal Investigator at Genome Institute of Singapore (GIS, A*STAR)
Professor Roger foo
Senior Consultant at the National University Heart Centre, National University Hospital System (NUHS) and Professor of Medicine at the National University Singapore Yong Loo Lin School of Medicine. Director of the NUHS Cardio-vascular Disease Translational Research Programme.
Professor Kosh ray
Honorary Consultant Cardiologist at the Imperial College NHS Trust and Professor of Public Health in the Department of Public Health and Primary Care at the Imperial College London. President of the European Atherosclerosis Society, as well as Fellow and member of prestigious medical and scientific societies, including the European Society of Cardiology and Royal College of Physicians.